Loading...
OTC Markets
Totals
Securities
12,241
Dollar Vol
$2.4B
Share Vol
3.3B
Trades
381,162

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

XALL
Xalles Holdings Inc.

Common Stock

0.0008

0.00

0.00%

0.0007 / 0.0009 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 08/01/2025
Delayed (15 Min) Trade Data: 12:00am 08/01/2025
OTC Disclosure & News Service
Xalles and CashX Amend Share Purchase Agreement


Xalles Holdings Inc. (OTC: XALL) today announced a major amendment to the CashXAI, Inc. (“CashX”) Share Purchase Agreement. CashX will return to being a private independent corporate entity so that it can take advantage of some unique fundraising and business opportunities. Xalles will have an opportunity to invest in CashX in the next funding round.  For clarity, CashX is no longer a wholly owned subsidiary of Xalles.


About Xalles Holdings Inc. (OTC Pink: XALL)
Xalles Holdings Inc. is a leading holding company, specializing in innovative technology and financial service solutions. Focused on growth and diversification, Xalles Holdings is committed to developing cutting-edge technology-based solutions across various sectors, with an emphasis on supporting disruptive companies. Utilizing its Xalles Studio, Xalles Advisors and M&A abilities, including its proprietary Xalles RISE Business Model (Roll In, Selected Exit), the company actively seeks targets with solid management teams, robust business models, expansive total attainable markets (TAM), and enticing exit opportunities. Xalles provides industry-leading solutions, poised to capture recurring revenue streams over time. Discover more at Xalles.com.

 

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at SEC.gov and in OTC Markets at OTCMarkets.com.


Investor Relations Contact:

IR@xalles.com

202.595.1299

Xalles.com

Page 1 of
Loading PDF...
OTCID Market Logo
OTCID
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.